News

Investing.com -- Dyne Therapeutics, Inc. (NASDAQ: DYN) reported a second quarter loss that slightly missed analyst expectations as the clinical-stage biotech company continues to advance its ...
The UK’s new industrial strategy signals a decisive shift toward state-backed innovation, investment, and regulatory reform.
On July 24, 2025, the Federal Trade Commission (“FTC”) and the U.S. Department of Justice (“DOJ”) convened the second of ...
Each year, the FDA approves a wide range of medications that help shape the future of medicine in the U.S. These include ...
Clarity Pharmaceuticals rocket up to 12% after its blitzkrieg placement • Artrya, Botanix and Imricor are among today’s ...
FDA issued CRLs for RP1 and glofitamab; CB-010 shows promise in lymphoma; osimertinib plus chemo extends NSCLC survival; and ...
Unpredictable FDA and funding woes delay crucial drug approvals, depriving thousands of patients access to vital treatments ...
Institutional investors including Armistice Capital, RTW Investments, and Wellington Management have increased their exposure ...
Overview of Companion Diagnostics MarketThe Companion Diagnostics Market is evolving rapidly, driven by the growing demand ...
Overview of Artificial Blood Cells MarketThe global Artificial Blood Cells Market is valued at USD 1.355 Billion in 2024 and is projected to reach a value of USD 5.265 Billion by 2035 at a CAGR ...
The appointment of a seasoned pharmaceutical executive, George Tidmarsh, to run the FDA’s drug center underscores the ...
NANJING, China, July 25, 2025 /PRNewswire/ -- On 25 July, 2025 (China Time), Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs" ...